Table 2.
Time period for temporal trends in age-adjusted cancer incidence for selected cancers by sex in Shanghai, 1973–2010
| Trend 1 | Trend 2 | Trend 3 | Trend 4 | Trend 5 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EAPC\(%)a | Years | EAPC(%) | Years | EAPC(%) | Years | EAPC(%) | Years | EAPC(%) | Years | EAPC(%) | |
| All sites | |||||||||||
| Male | −0.41* | 1973–1996 | −0.79* | 1996–2001 | 2.29 | 2001–2010 | −1.65* | ||||
| Female | 0.57* | 1973–1980 | −3.01* | 1980–1996 | 0.30 | 1996–2001 | 4.38* | 2001–2010 | −0.14 | ||
| Esophagus | |||||||||||
| Male | −4.23* | 1973–1994 | −5.14* | 1994–2001 | −0.39 | 2001–2010 | −6.58* | ||||
| Female | −5.45* | 1973–2010 | −5.45* | ||||||||
| Stomach | |||||||||||
| Male | −2.66* | 1973–1989 | −1.67* | 1989–1995 | −5.36* | 1995–2000 | 0.44 | 2000–2010 | −4.23* | ||
| Female | −1.84* | 1973–1989 | −1.00* | 1989–1995 | −3.84* | 1995–2000 | 1.16 | 2000–2010 | −3.88* | ||
| Colorectum | |||||||||||
| Male | 2.37* | 1973–2010 | 2.37* | ||||||||
| Female | 2.13* | 1973–1995 | 2.15* | 1995–2002 | 4.18* | 2002–2010 | −1.65* | ||||
| Liver | |||||||||||
| Male | −1.56* | 1973–1996 | −1.77* | 1996–2002 | 0.79 | 2002–2010 | −3.97* | ||||
| Female | −1.76* | 1973–2010 | −1.76* | ||||||||
| Gallbladder & biliary tract | |||||||||||
| Male | 3.15* | 1973–2000 | 4.44* | 2000–2010 | −2.31 | ||||||
| Female | 2.80* | 1973–1987 | 5.53* | 1987–1995 | 1.87 | 1995–2000 | 6.68 | 2000–2010 | −3.72* | ||
| Pancreas | |||||||||||
| Male | 1.67* | 1973–1982 | 4.00* | 1982–2010 | 1.25* | ||||||
| Female | 1.61* | 1973–2010 | 1.61* | ||||||||
| Lung | |||||||||||
| Male | −0.58* | 1973–1989 | 0.79* | 1989–1994 | −2.93 | 1994–1999 | 2.52 | 1999–2010 | −3.45* | ||
| Female | 0.14 | 1973–1995 | −0.29 | 1995–2001 | 3.07 | 2001–2010 | −1.89* | ||||
| Kidney & renal pelvis | |||||||||||
| Male | 6.41* | 1973–1981 | −1.03 | 1981–2010 | 7.54* | ||||||
| Female | 5.42* | 1973–1980 | −4.48 | 1980–2010 | 6.60* | ||||||
| Bladder | |||||||||||
| Male | 0.82* | 1973–2010 | 0.82* | ||||||||
| Female | 0.59* | 1973–1991 | −0.89 | 1991–2010 | 1.97* | ||||||
| CNS | |||||||||||
| Male | 1.85* | 1973–1980 | −1.09 | 1980–1989 | 5.57* | 1989–2010 | 0.52 | ||||
| Female | 2.99* | 1973–1980 | −2.28 | 1980–1985 | 8.54 | 1985–2003 | 3.31* | 2003–2010 | −1.67 | ||
| Thyroid | |||||||||||
| Male | 2.77* | 1973–1978 | 0.85 | 1978–1983 | −15.81* | 1983–2001 | 3.60* | 2001–2010 | 18.10* | ||
| Female | 3.47* | 1973–1984 | −9.58* | 1984–2002 | 5.57* | 2002–2010 | 17.72* | ||||
| NHL | |||||||||||
| Male | 1.64* | 1973–2010 | 1.64* | ||||||||
| Female | 2.50* | 1973–2010 | 2.50* | ||||||||
| Leukemia | |||||||||||
| Male | 0.13 | 1973–2010 | 0.13 | ||||||||
| Female | −0.17 | 1973–1997 | −1.09* | 1997–2010 | 2.13* | ||||||
| Prostate | 6.89* | 1973–1989 | 0.51 | 1989–2004 | 12.62* | 2004–2010 | 3.59 | ||||
| Female breast | 2.89* | 1973–1981 | −0.17 | 1981–1990 | 4.45* | 1990–1996 | 0.77 | 1996–2001 | 7.91* | 2001–2010 | 0.23 |
| Cervix | −3.44* | 1973–1980 | −19.07* | 1980–1996 | −6.99* | 1996–2010 | 8.94* | ||||
| Corpus uteri | 3.06* | 1973–1996 | 2.52* | 1996–2001 | 10.24* | 2001–2010 | −2.00 | ||||
| Ovary | 2.07* | 1973–1984 | −0.55 | 1984–2005 | 3.50* | 2005–2010 | −5.66 | ||||
aEAPC: estimated annual percent change in age-adjusted incidence rates, from join point analysis using Joinpoint software. *Estimated annual percentage change (EAPC) significantly different from zero (P < 0.05)